Eagle Bay Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-57
| Closed | -$2.68K | – | 318 |
|
|
2024
Q4 | $2.68K | Hold |
57
| – | – | ﹤0.01% | 811 |
|
|
2024
Q3 | $3.01K | Hold |
57
| – | – | ﹤0.01% | 1135 |
|
|
2024
Q2 | $3.09K | Hold |
57
| – | – | ﹤0.01% | 820 |
|
|
2024
Q1 | $4K | Hold |
57
| – | – | ﹤0.01% | 778 |
|
|
2023
Q4 | $4.76K | Hold |
57
| – | – | ﹤0.01% | 640 |
|
|
2023
Q3 | $1.68K | Hold |
57
| – | – | ﹤0.01% | 778 |
|
|
2023
Q2 | $1.86K | Hold |
57
| – | – | ﹤0.01% | 771 |
|
|
2023
Q1 | $2.01K | Hold |
57
| – | – | ﹤0.01% | 755 |
|
|
2022
Q4 | $2.61K | Hold |
57
| – | – | ﹤0.01% | 722 |
|
|
2022
Q3 | $3K | Hold |
57
| – | – | ﹤0.01% | 719 |
|
|
2022
Q2 | $2.24K | Buy |
+57
| New | +$2.24K | ﹤0.01% | 779 |
|
|
2022
Q1 | – | Sell |
-57
| Closed | -$3K | – | 448 |
|
|
2021
Q4 | $3K | Buy |
+57
| New | +$3K | ﹤0.01% | 829 |
|